Head-To-Head Analysis: NovelStem International (OTCMKTS:NSTM) & EVgo (NYSE:EVGO)

NovelStem International (OTCMKTS:NSTMGet Rating) and EVgo (NYSE:EVGOGet Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations.

Analyst Ratings

This is a summary of recent recommendations and price targets for NovelStem International and EVgo, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NovelStem International 0 0 0 0 N/A
EVgo 1 2 6 0 2.56

EVgo has a consensus price target of $13.44, suggesting a potential upside of 48.48%. Given EVgo’s higher possible upside, analysts clearly believe EVgo is more favorable than NovelStem International.

Insider & Institutional Ownership

0.1% of NovelStem International shares are held by institutional investors. Comparatively, 13.7% of EVgo shares are held by institutional investors. 13.6% of NovelStem International shares are held by company insiders. Comparatively, 74.5% of EVgo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares NovelStem International and EVgo’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NovelStem International N/A N/A N/A
EVgo -52.62% N/A -8.17%

Valuation & Earnings

This table compares NovelStem International and EVgo’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NovelStem International N/A N/A N/A N/A N/A
EVgo $22.21 million 107.93 -$5.91 million ($0.24) -37.71

NovelStem International has higher earnings, but lower revenue than EVgo.

Volatility and Risk

NovelStem International has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Comparatively, EVgo has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500.

Summary

EVgo beats NovelStem International on 6 of the 8 factors compared between the two stocks.

About NovelStem International

(Get Rating)

NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.

About EVgo

(Get Rating)

EVgo, Inc. owns and operates a direct current fast charging network in the United States. The company offers electricity directly to drivers, who access its publicly available networked chargers; original equipment manufacturer charging and related services; fleet and rideshare public charging services; and charging as a service and fleet dedicated charging services. It also provides ancillary services, such as customization of digital applications, charging data integration, loyalty programs, access to chargers behind parking lot, or garage, pay gates and pilots microtargeted advertising, and charging reservations; and maintenance and development and project management services through eXtendTM, including electric vehicle supply equipment installation, networking, and operations. The company was incorporated in 2010 and is based in Los Angeles, California.

Receive News & Ratings for NovelStem International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovelStem International and related companies with MarketBeat.com's FREE daily email newsletter.